© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 22, 2009
January 21, 2009
Marc Rothenberg, MD, PhD: EoE Receives First FDA Approval with Dupilumab
Systematic Review Suggests Oral JAK Inhibitors Effective in AD
Study Identifies 24 Adverse Events Associated with Secukinumab Treatment